Floatz logo

Citicoline

Amphetamine Dependence

Deborah Yurgelun-ToddSmall moleculeN/ADormant
D
30/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
15/ 100
Competitive Position
95/ 100

Competitive context

0 Active assets in the Amphetamine Dependence cohort.

Asset / SponsorPhaseRating
Seroquel®
Creighton University
Phase 4BB
Valproic Acid
Creighton University
Phase 4BB
ASCRINVACUMAB
Suzhou Kintor Pharmaceutical Inc,
Phase 1/2CCC
Nivolumab
Suzhou Kintor Pharmaceutical Inc,
Phase 1/2CCC
Risperdal
Tel-Aviv Sourasky Medical Center
Phase 4NR
gsk598809 capsules
GlaxoSmithKline
Phase 1NR

Same molecule, other indications

Citicoline is also rated in:

cerebral infarctionDormant
B
Indicative ·
62 / 100
View asset →
cocaine dependenceDormant
B
Indicative ·
60 / 100
View asset →
stroke disorderDormant
B
Indicative ·
57 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →